Wang, AnqiKogevinas, ManolisCastaño Vinyals, GemmaHaiman, Christopher A.2024-02-202023Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat Genet. 2023 Dec;55(12):2065-74. DOI: 10.1038/s41588-023-01534-41061-4036http://hdl.handle.net/10230/59184The transferability and clinical value of genetic risk scores (GRSs) across populations remain limited due to an imbalance in genetic studies across ancestrally diverse populations. Here we conducted a multi-ancestry genome-wide association study of 156,319 prostate cancer cases and 788,443 controls of European, African, Asian and Hispanic men, reflecting a 57% increase in the number of non-European cases over previous prostate cancer genome-wide association studies. We identified 187 novel risk variants for prostate cancer, increasing the total number of risk variants to 451. An externally replicated multi-ancestry GRS was associated with risk that ranged from 1.8 (per standard deviation) in African ancestry men to 2.2 in European ancestry men. The GRS was associated with a greater risk of aggressive versus non-aggressive disease in men of African ancestry (P = 0.03). Our study presents novel prostate cancer susceptibility loci and a GRS with effective risk stratification across ancestry groups.application/pdfeng© Springer Nature Publishing AG [Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat Genet. 2023 Dec;55(12):2065-74] [http://dx.doi.org/10.1038/s41588-023-01534-4]info:eu-repo/semantics/articlehttp://dx.doi.org/10.1038/s41588-023-01534-4Genetics researchGenome-wide association studiesPreventive medicineProstate cancerinfo:eu-repo/semantics/openAccess